Big Data In Medicines Regulation Will Need ‘Considerable Change In Mindset’

 
• By Maureen Kenny

Changing mindsets, technologies outpacing regulatory frameworks, intense international collaboration, and the future of the randomized controlled clinical trial. Big data is forcing us to think big, senior European regulator Thomas Senderovitz tells the Pink Sheet.

PS1808_Big Data_176189567_1200.jpg
Proposals on the use of big data in drug evaluation are under development • Source: Shutterstock

More from Europe

More from Geography